We are live on ! Find out more
ALIM

Alimera Sciences
ALIM

Delisted

ALIM was delisted on the 13th of September, 2024.

Back to rankings

41 hedge funds and large institutions have $31.7M invested in Alimera Sciences in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

5% more funds holding

Funds holding: 39 → 41 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

17% less capital invested

Capital invested by funds: $38.2M → $31.7M (-$6.49M)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
6
Reduced
9
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
+$1.05M
2
Renaissance Technologies
Renaissance Technologies
New York
+$122K
3
TRCT
Tower Research Capital (TRC)
New York
+$51.3K
4
DMK
David M. Knott
+$39K
5
BRWM
B. Riley Wealth Management
Tennessee
+$19.9K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.03M
2
BRF
B. Riley Financial
California
-$303K
3
BlackRock
BlackRock
New York
-$135K
4
Citadel Advisors
Citadel Advisors
Florida
-$97K
5
SCM
Stonepine Capital Management
Oregon
-$41.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$16K +$16.7K +1,183 New
MCM
27
Mainstay Capital Management
Michigan
$14K – – –
Millennium Management
28
Millennium Management
New York
$14K +$14.7K +1,044 New
UBS Group
29
UBS Group
Switzerland
$13K +$14.1K +1,000 New
SCM
30
Southport Capital Management
Tennessee
$10K – – –
SWM
31
SeaCrest Wealth Management
New York
$9K – – –
SRC
32
Shufro Rose & Co
New York
$9K – – –
Bank of America
33
Bank of America
North Carolina
$5K +$4.83K +343 New
PCM
34
Prelude Capital Management
New York
$1K -$28 -2 -3%
S
35
SignatureFD
Georgia
$1K – – –
FWM
36
Focused Wealth Management
New York
$1K +$943 +67 New
BRWM
37
B. Riley Wealth Management
Tennessee
$143 +$19.9K +1,417 +15%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$4 – – –
BRF
39
B. Riley Financial
California
– -$303K -19,067 Closed
Citadel Advisors
40
Citadel Advisors
Florida
– -$97K -6,089 Closed
FIM
41
Freedom Investment Management
Connecticut
– -$13K -820 Closed
CFGS
42
Concourse Financial Group Securities
Alabama
– -$943 -67 Closed
LTFS
43
Ladenburg Thalmann Financial Services
Florida
– -$1K -67 Closed
Barclays
44
Barclays
United Kingdom
– -$507 -36 -86%
PAM
45
Panagora Asset Management
Massachusetts
– +$479 +34 New
1
2

ALIM Hedge Fund Activity: Q2 2019 in Review

41 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2019, worth a combined $31.7M — down 17% from $38.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ALIM positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 9 trimmed.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $1.05M. The largest seller was Armistice Capital, cutting an estimated $1.03M.

  • 41 institutional investors held Alimera Sciences (ALIM) as of Q2 2019, up from 39 in Q1 2019.
  • Funds reported $31.7M of Alimera Sciences stock for Q2 2019, down 17% quarter-over-quarter.
  • 7 funds opened new Alimera Sciences positions in Q2 2019 and 5 closed out, a net change of +2 holders.
  • The largest Alimera Sciences buyer in Q2 2019 was Boothbay Fund Management, an estimated $1.05M added.
  • The largest Alimera Sciences seller in Q2 2019 was Armistice Capital, an estimated $1.03M sold.

Based on aggregated 13F filings for Q2 2019.